Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24153334 | 0.82 | KMT2A (0.34) | ALOX12KMT2AATMKDM4EPOLB | |
| SCHEMBL13479718 | 0.81 | ALOX12 (0.37) | ALOX12KMT2AATMKDM4EPOLB | |
| SCHEMBL16340691 | 0.79 | POLB (0.42) | KMT2APOLBLMNASMN1; SMN2MAPT | |
| SCHEMBL17903314 | 0.77 | ALOX12 (0.46) | ALOX12KMT2AATMKDM4EPOLB | |
| SCHEMBL24152404 | 0.76 | ALOX12 (0.34) | ALOX12SMN1; SMN2MAPT | |
| SCHEMBL9516281 | 0.75 | ALDH1A1 (0.33) | LMNAMAPT | |
| SCHEMBL28933285 | 0.74 | ALOX12 (0.42) | ALOX12KMT2AATMKDM4EPOLB | |
| SCHEMBL14387773 | 0.71 | KMT2A (0.36) | KMT2AATMGLA | |
| SCHEMBL18969713 | 0.71 | ALOX12 (0.36) | ALOX12KMT2AKDM4EPOLBSMN1; SMN2 | |
| SCHEMBL11339328 | 0.70 | ALOX12 (0.41) | ALOX12KDM4EPOLBLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114085317-A | Reactive UCST copolymer and preparation method thereof | 中国医学科学院生物医学工程研究所 | 2022-02-25 | — | — | CN | claimed |
| US-10369227-B2 | Immunocompatible polymers | MCMASTER UNIVERSITY (CA) | 2019-08-06 | — | — | US | claimed |
| US-20140309313-A1 | IMMUNOCOMPATIBLE POLYMERS | MCMASTER UNIVERSITY (CA) | 2014-10-16 | — | — | US | claimed |
| US-8815283-B2 | Immuno-compatible hydrogel system | MCMASTER UNIVERSITY (CA) | 2014-08-26 | — | — | US | claimed |
| US-20130177976-A1 | COMBINATION OF CATIONIC POLYMERS AND POLYSACCHARIDES NANOPARTICLES AS A GENE CARRIER | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-07-11 | — | — | US | claimed |
| US-20130136714-A1 | FUNCTIONALIZED POLYMER NANOPARTICLES AND THE PHARMACEUTICAL USE THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2013-05-30 | — | — | US | claimed |
| US-20120107394-A1 | IMMUNO-COMPATIBLE HYDROGEL SYSTEM | MCMASTER UNIVERSITY (CA) | 2012-05-03 | — | — | US | claimed |
| EP-2438115-A1 | IMMUNO-COMPATIBLE HYDROGEL SYSTEM | Stover, Harald (CA) | 2012-04-11 | — | — | EP | claimed |
| US-8133411-B2 | Fluorescent polymers soluble in an aqueous solution and a method for the production thereof | BIOMERIEUX S.A. (FR) | 2012-03-13 | — | — | US | claimed |
| WO-2010139061-A1 | IMMUNO-COMPATIBLE HYDROGEL SYSTEM | STOVER HARALD (CA) | 2010-12-09 | — | — | WO | claimed |
| EP-1701741-A2 | COMPLEXES HAVING ADJUVANT ACTIVITY | Polytherics Limited (GB) | 2006-09-20 | — | — | EP | claimed |
| US-7071265-B2 | Copolymerization of N-acryloxysuccinimide or N-methacryloxy-succinimide with methyl methacrylate, in the presence activators, solvents and stabilizer agents to form narrow particle size distribution copolymers | FUJI XEROX CO., LTD. (JP) | 2006-07-04 | — | — | US | claimed |
| EP-1290052-B1 | BIOCOMPATIBLE POLYMER FOR FIXING BIOLOGICAL LIGANDS | BIO MERIEUX (FR) | 2006-05-03 | — | — | EP | claimed |
| US-6969742-B2 | Method of producing a functional polymer particle | FUJI XEROX CO., LTD. (JP) | 2005-11-29 | — | — | US | claimed |
| WO-2005065712-A2 | COMPLEXES HAVING ADJUVANT ACTIVITY | POLYTHERICS LIMITED (GB) | 2005-07-21 | — | — | WO | claimed |
| US-6914100-B2 | Method of producing a crosslinked polymer particle | FUJI XEROX, CO., LTD. (JP) | 2005-07-05 | — | — | US | claimed |
| US-20040091451-A1 | Biocompatible polymer for fixing biological ligands | BIO MERIEUX (FR) | 2004-05-13 | — | — | US | claimed |
| US-20040039109-A1 | Method of producing a functional polymer particle | FUJI XEROX CO., LTD. (JP) | 2004-02-26 | — | — | US | claimed |
| US-20040034171-A1 | Method of producing a non-crosslinked polymer particle | FUJI XEROX CO., LTD. (JP) | 2004-02-19 | — | — | US | claimed |
| US-20040034174-A1 | Method of producing a crosslinked polymer particle | FUJI XEROX CO., LTD. (JP) | 2004-02-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091451-A1 | Biocompatible polymer for fixing biological ligands | CD40, FCGR1A, CD47 | ALOX12 3551/4885KMT2A 2399/4885ATM 4681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.